Central Venous Oxygen Saturation above 75% on Day Three of Septic Shock is Associated with Tripled Mortality

Timo Sturm, Jan Dertinger, M. Hagmann, M. Thiel, Verena Schneider-Lindner
{"title":"Central Venous Oxygen Saturation above 75% on Day Three of Septic Shock is Associated with Tripled Mortality","authors":"Timo Sturm, Jan Dertinger, M. Hagmann, M. Thiel, Verena Schneider-Lindner","doi":"10.4172/2332-0877.1000338","DOIUrl":null,"url":null,"abstract":"Background: Central venous oxygen saturation (ScvO2) is commonly used to identify global oxygen uptakedelivery mismatches. A level above 70% was the declared goal in early resuscitation of septic shock for over a decade. Recent evidence leads to doubts and levels higher than 80% may represent harmful conditions. This study ´s aim was to identify favourable ScvO2 levels in treatment of septic shock. \nMethods: Electronic data of patients suffering from septic shock who have been admitted to the surgical intensive care unit of a university hospital were analysed surveying a period of six years with focus on the association of ScvO2 levels with in-hospital mortality. \nResults: Data from 238 individuals were included. No difference was found comparing initially measured values of ScvO2 of survivors to non-survivors. Patients whose levels of ScvO2 never exceeded 70% (n=28) had a higher mortality rate (73.2% vs. 54.3%, p<0.05). On day three patients with values above 75% (n=32) had higher mortality rates (59.4% vs. 38.5%, p<0.05). A mortality rate of 100% was detected if ScvO2 levels exceeded 84% (n=6). \nConclusions: ScvO2 develops from a therapy guiding parameter to a prognostic marker. Reaching levels of at least 70% within the first 72 h of disease is favourable in regard to prognosis. Exceeding 75% after day two is associated with higher mortality. These findings require further confirmation. At this point it can be assumed that a varying, time-dependent ScvO2 approach might be required for clinical decision-making.","PeriodicalId":73792,"journal":{"name":"Journal of infectious disease and therapy","volume":"2017 1","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2332-0877.1000338","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of infectious disease and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2332-0877.1000338","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Central venous oxygen saturation (ScvO2) is commonly used to identify global oxygen uptakedelivery mismatches. A level above 70% was the declared goal in early resuscitation of septic shock for over a decade. Recent evidence leads to doubts and levels higher than 80% may represent harmful conditions. This study ´s aim was to identify favourable ScvO2 levels in treatment of septic shock. Methods: Electronic data of patients suffering from septic shock who have been admitted to the surgical intensive care unit of a university hospital were analysed surveying a period of six years with focus on the association of ScvO2 levels with in-hospital mortality. Results: Data from 238 individuals were included. No difference was found comparing initially measured values of ScvO2 of survivors to non-survivors. Patients whose levels of ScvO2 never exceeded 70% (n=28) had a higher mortality rate (73.2% vs. 54.3%, p<0.05). On day three patients with values above 75% (n=32) had higher mortality rates (59.4% vs. 38.5%, p<0.05). A mortality rate of 100% was detected if ScvO2 levels exceeded 84% (n=6). Conclusions: ScvO2 develops from a therapy guiding parameter to a prognostic marker. Reaching levels of at least 70% within the first 72 h of disease is favourable in regard to prognosis. Exceeding 75% after day two is associated with higher mortality. These findings require further confirmation. At this point it can be assumed that a varying, time-dependent ScvO2 approach might be required for clinical decision-making.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
败血症休克第三天中心静脉血氧饱和度高于75%与死亡率三倍相关
背景:中心静脉氧饱和度(ScvO2)通常用于识别整体氧摄取递送不匹配。十多年来,在脓毒性休克的早期复苏中,70%以上是公认的目标。最近的证据引起了怀疑,高于80%的水平可能代表有害状况。本研究的目的是确定治疗感染性休克的有利ScvO2水平。方法:对某大学附属医院外科重症监护病房收治的感染性休克患者6年的电子数据进行分析,重点分析ScvO2水平与住院死亡率的关系。结果:纳入238人的数据。比较幸存者和非幸存者的ScvO2初始测量值没有发现差异。ScvO2水平从未超过70%的患者(n=28)死亡率更高(73.2% vs. 54.3%, p<0.05)。第3天,值大于75%的患者(n=32)死亡率较高(59.4% vs. 38.5%, p<0.05)。如果ScvO2水平超过84%,则检测到100%的死亡率(n=6)。结论:ScvO2已从治疗指导参数发展为预后指标。在发病后72小时内达到至少70%的水平有利于预后。2天后超过75%与更高的死亡率相关。这些发现需要进一步证实。在这一点上,可以假设临床决策可能需要一种变化的、随时间变化的ScvO2方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Mycobacterial Nucleic Acids Modulate Host Innate Immune Responses. Streptococcus Pharyngitis with Anaerobes Infection Misdiagnosed as Mycobacterium Tuberculosis Infection: A Case Report The Intervening Effect of Preventive Use of Antibacterials During the Perioperative Period in Orthopedic Department Outcome Comparison Between Tocilizumab Alone Vs Tocilizumab Followed by Intravenous Immunoglobulin (IVIG) Group in Critical COVID-19 Disease To What Extent do Social Determinants of Health Modulate Presentation, ITU Admission and Outcomes among Patients with SARS-COV-2 Infection? An Exploration of Household Overcrowding, Air Pollution, Housing Quality, Ethnicity, Comorbidities and Frailty.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1